Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Obesity is a chronic metabolic disease affecting adults and children worldwide. It has become one of the leading causes of death, as obesity is known to be the main risk factor for a number of non-communicable diseases, in particular type 2 diabetes. This close relationship led to the connotation ‘diabesity', highlighting the fact that the majority of individuals with diabetes are overweight or obese. Until today the BMI is still used to classify overweight and obesity. Since reduced muscle mass is highly prevalent throughout the BMI range, the measurement of body composition is strongly recommended. Moreover, it is essential for monitoring the course of weight reduction, which is part of every effective anti-obesity treatment. Weight reduction can be achieved via different weight loss strategies, including lifestyle intervention (diet and exercise), pharmacotherapy, or bariatric surgery. However, not all of these strategies are suitable for all patients, and any further needs should be considered. Besides, attention should also be drawn to concomitant therapies. These therapies may promote additional weight gain and further trigger the deterioration of blood glucose control. Thus, therapeutic strategies are warranted, which can be easily used for the management of obese patients with type 2 diabetes to achieve their glycemic and weight loss goals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity and T2D share key pathophysiological mechanisms and are both associated with increased risk for (i) metabolic complications [such as hypertension, dyslipidemia, obstructive sleep apnea (OSA) and metabolic-dysfunction associated steatotic liver disease (MASLD)] and (ii) cardiovascular disease [2,4].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
In the citing paper
“Obesity is the strongest risk factor for T2D and the obesity epidemic is heavily contributed to the rise of T2D prevalence, especially the increased rates of young-onset T2D [2].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Cited by
Items 301–400 of 430
Kang, J.-K., Lee, E. H., Yoon, B. H., Jeon, M., Chung, J.-W., Song, P. H., Kwon, T. G., Ha, Y., Chun, S. Y., Lee, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110352 · Cited by 1
Glyoxalase 1 is a proadipogenic gene
Trujillo, M. N., Zhang, W., Hoffman, E. A., Kitamura, N., Phoebe, A. M., & Galligan, J. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110926 · Cited by 1
“MGO metabolism has been heavily implicated in the progression of T2D, and studies have mainly focused on correlations between increased MGO and MGO-derived PTMs and disease.”
InfluentialPhysicochemical Analysis and Digestive Enzymes Inhibition of a Selected Malaysian Apis cerana Honey
Mustar, S., Ibrahim, N., Pauzi, N. A., Rashed, A. A., & Noh, M. F. M. (2025) · Foods · doi:10.3390/foods14223958 · Cited by 1
“The implications of obesity and diabetes are causing more health problems, leading to other ailments such as heart disease and kidney problems, reduced productivity, quality of life, and longevity [3].”
Transcutaneous allicin oleogel restores energy homeostasis for obesity treatment
Xu, Q.-G., Gu, Z.-Y., Chen, W.-J., Liu, H., Li, Z.-Y., Cai, W.-L., Huang, J., Muhitdinov, B. I., Liu, E.-G., Aisa, H. A., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01768-y · Cited by 2
“Obesity is often accompanied by insulin resistance, which can lead to type 2 diabetes [34].”
Zhang, J., Lin, Z., Zhong, S., Ma, M., Wong, H. K., Li, L., Lo, K. K. H., & Bian, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1843491 · Cited by 1
“Notably, T2DM frequently co-occurs with metabolic syndrome (MetS), present in roughly 85% of individuals (5, 6) and characterized by a cluster of abdominal obesity, elevated arterial blood pressure, atherogenic dyslipidemia, elevated plasma glucose, proin-fl ammatory states, and prothrombotic states…”
Emara, A., Emara, M., Mansour, A., Elkholy, M., Abbas, O., Abdul‐Hafez, H. A., Azzawi, M. A. D. A., & Shubietah, A. R. M. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02218-9 · Cited by 1
“…contribution of this review is therefore not simply that orforglipron appears effective, but that this efficacy remains evident in the specific subgroup of adults with both obesity and T2DM, where simultaneous improvement in weight and glycemic con-trol is especially important [12, 30–34].”
Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
Bonizzi, A., Sevieri, M., Sitia, L., Rizzi, A., Conti, L., Corsi, F., Morasso, C., & Mazzucchelli, S. (2021) · Applied Sciences · doi:10.3390/app112210710 · Cited by 1
The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients
ÖZTÜRK, G., Ak, M. A., & Ertop, Ş. (2021) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.1037628 · Cited by 1
Gupta, S., Goel, V., Nazir, N., Srivastava, S., & Srivastava, A. (2022) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v13i1.41396 · Cited by 1
Giha, H. A., Joatar, F. E., AlDehaini, D. M. B., Malalla, Z. H. A., Ali, M. E., & Qarni, A. A. A. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0063 · Cited by 2
Davoudi, Z., Zahed, N. S., Tabatabaei, S.-S., Farsi, Y., Soori, M., & Mirhashemi, S. H. (2022) · Journal of Renal Injury Prevention · doi:10.34172/jrip.2022.32028 · Cited by 1
“Obesity is a strong risk factor for the development of type 2 diabetes (T2DM), progression of chronic kidney disease, and end-stage renal disease (ESRD)(1, 2).”
BackgroundWijayanti, E., Samsuria, I. K., & Widyaningrum, D. (2022) · Biomedika · doi:10.23917/biomedika.v14i2.18629 · Cited by 1
Taste dyfunction in obese type 2 diabetic individuals
Hasan, A. Z., Preethi, B. L., Kalra, P., & Arun Kumar, M. (2022) · Indian Journal of Clinical Anatomy and Physiology · doi:10.18231/j.ijcap.2022.040 · Cited by 1
تأثير الصمغ العربى والوجبات عالية الدهون على الفئران المصابة بالسمنة
شاهين, خ. ع., & أبورية, س. (2022) · Mağallaẗ Al-Iqtiṣād Al-Manzilī - Ǧāmiʿaẗ Al-Munūfiyyaẗ · doi:10.21608/mkas.2022.166482.1178 · Cited by 1
Idowu, A., Amole, I. O., Durodola, A. O., Adesina, S. A., Adegoke, A. O., Akinwumi, A. I., Idowu, O. A., Awotunde, O. T., & OlaOlorun, A. D. (2022) · International Journal of TROPICAL DISEASE & Health · doi:10.9734/ijtdh/2022/v43i231371 · Cited by 1
Elrggal, M. E., Elkeraie, A. F., Carriazo, S. M., Sawaf, H., Khor, S. Y., Elkeraie, Y., Haddad, I. R., Moustafa, K., & Hassanein, M. M. (2023) · Frontiers in clinical drug research. Diabetes and obesity · doi:10.2174/9789815123586123070009 · Cited by 1
Rathod, N., Gond, B., Kewat, M., Tambe, A., & Puralkar, S. (2023) · Asian Journal of Medicine and Health · doi:10.9734/ajmah/2023/v21i9852 · Cited by 6
“This refers to a low-fat and low-carbohydrate diet [5].”
Background(2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.309962 · Cited by 1
“Obesity is an underlying cause for many non-communicable diseases as hypertension and diabetes mellitus later in life [2] .”
BackgroundComparison of Machine Learning Algorithms for Obesity Prediction
Fernandes, A., Dahikar, S., Chopra, K. L., & Saxena, K. (2023) · Asian Conference on Innovation in Technology (ASIANCON) · doi:10.1109/asiancon58793.2023.10270246 · Cited by 1
Stress and human health in diabetes: A report from the 19th Chicago Biomedical Consortium symposium
Mirmira, R. G., Kulkarni, R. N., Xu, P., Drossos, T., Varady, K. A., Knutson, K. L., Reutrakul, S., Martyn-Nemeth, P. A., Sargis, R. M., Wallia, A., et al. (2023) · Journal of Clinical and Translational Science · doi:10.1017/cts.2023.646 · Cited by 3
“…syndrome is a cluster of conditions – including obesity, high fasting blood glucose, high blood pressure, and dyslipidemia – that together put tremendous stress on the body and greatly increase the risk ofdevelopingtype2 diabetes, obesity,cardiovasculardisease, and other health problems [22].”
BackgroundObesity-mediated insulin resistance in target tissues: role of adiponectin, fetuin-A, and irisin
Mukherjee, S., Das, S., Chattopadhyay, D., & Mukhopadhyay, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00041-4 · Cited by 3
Remisión progresiva de antidiabéticos en pacientes obesos sometidos a cirugía bariátrica
Tamayo-Malusin, M. E., & Morales-Solís, J. M. (2024) · MQRInvestigar · doi:10.56048/mqr20225.8.1.2024.2418-2438
(2024) · Jordan Journal of Biological Sciences · doi:10.54319/jjbs/170110 · Cited by 5
“Obesity is associated with an increased risk factor for several non-communicable diseases (Leitner et al., 2017).”
BackgroundTHE IMPACT OF PHYSICAL INACTIVITY AND OBESITY ON HEALTH EXPENDITURES IN TÜRKİYE
YÜCEL, A. S., GÜMÜŞDAĞ, H., Özpınar, S., Perihan, A. B. A. Y., DERMAN, S., & Korkmaz, M. (2023) · Uluslararası hakemli akademik spor sağlık ve tıp bilimleri dergisi · doi:10.17363/sstb.2023/abcd89/.49.1 · Cited by 2
Gahlot, U., Sharma, Y. K., Patel, J., & Sugadev, R. (2024) · Population Health Metrics · doi:10.1186/s12963-024-00349-7 · Cited by 1
Asociación entre variables sociodemográficas, hábitos saludables y estrés con diabesidad
López‐González, Á. A., Rifá, E. M.-A., Oliveira, H. P., Sánchez, C. M., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2024.500754 · Cited by 2
Herencia, J. A. C., Rueda, M. S., Ródenas, L. M. A., Divisón, J. A., Escribano, F. M., García, I. P., Bru, A. P., Moreno, P. T., Bernardo, D. C., López, R. M., et al. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500768 · Cited by 1
Voros, C., Mavrogianni, D., Bananis, K., Karakasis, A., Papahliou, A.-M., Topalis, V., Varthaliti, A., Mantzioros, R., Kondili, P., Darlas, M., et al. (2025) · Antioxidants · doi:10.3390/antiox14020240 · Cited by 1
Khor, W.-T., Chang, Y., Lin, H.-M., Chi, K., Song, J., Chen, C., & Huang, C.-C. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2025.124595 · Cited by 1
Multidisciplinary care of diabetic feet
Barbachan, A., Borges, V. Q., Ferreira, G. F., Sacilotto, R., Portes, E., & Stéfani, K. C. (2019) · Journal of the Foot & Ankle · doi:10.30795/scijfootankle.2019.v13.913 · Cited by 1
Aging, circadian clock, and neurogenesis: the zebrafish approach
Zhdanova, I. V., & Stankiewicz, A. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817528-6.00025-5 · Cited by 1
DIFERENÇAS DE GÊNERO NA DIABETES: UM PONTO DE PARTIDA PARA OTIMIZAR A QUALIDADE DE VIDA
Coelho, F. M., & Ripoll, E. M. (2020) · Revista de Enfermagem e Atenção à Saúde · doi:10.18554/reas.v9i1.3730 · Cited by 4
“2016 [citado em 10 mar 2019]; 5(2):34-44.”
BackgroundEleazu, C. O., & Mohamed, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_14 · Cited by 1
MC4R as a Target for Pharmacotherapeutic Treatment of Obesity and Type 2 Diabetes
Gonçalves, J. P. L., Palmer, D., & Meldal, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_69 · Cited by 2
Beyene, Z. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.47191/ijpbms/v1-i7-02 · Cited by 2
Omar, G., Khalid, M., & Ghanem, A. (2022) · Journal of Medicine in Scientific Research · doi:10.4103/jmisr.jmisr_60_21 · Cited by 1
Shahid, S. M. (2020) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000234
Hip circumference correlates negatively with insulin resistance in type 2 diabetic patients
Wali, N., Mukhtar, I. G., & Ibrahim, S. (2020) · Sahel Medical Journal · doi:10.4103/smj.smj_14_19
Next-generation probiotics and obesity—A mini systematic review
Kathera, C., & Viswanath, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821406-0.00003-5
Obesity Treatment Can Also Cure Type 2 Diabetes Mellitus: A Case Report
Akbaş, F., & Atmaca, H. U. (2020) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2020.50465
Body Mass Index and Its Association with Genetically Transmitted Traits
Alasmari, S., Eisa, N., Alshahrani, S. M., Alam, M. M., Rajagopalan, P., & Makkawi, M. (2020) · BioMed Research International · doi:10.1155/2020/3469316 · Cited by 1
Shevchenko, O., & Петрук, Н. С. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.01.033
Pustovalov, A. S., Tkachenko, O., Matviienko, M., & Dzerzhynsky, M. E. (2020) · Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology” · doi:10.17721/1728_2748.2020.83.37-43
Petryk, N., & Shevchenko, O. (2020) · Inter Collegas · doi:10.35339/ic.7.3.109-117
The Double Whammy of Obesity and Diabetes on Female Reproductive Health
Thong, E. P., & Burden, C. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1723777 · Cited by 2
de Oliveira, R. A. F., Moimaz, S. A. S., Garbin, C. A. S., Garbín, A. J. Í., & Chiba, F. Y. (2021) · Research Society and Development · doi:10.33448/rsd-v10i5.14776
Finocchietto, P., Perez, H., Blanco, G., Miksztowicz, V., Marotte, C., Morales, C., Peralta, J., Berg, G., Poderoso, C., Poderoso, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.23.453523
Ohakosim, A. N. (2021) · Cited by 1
Association between Depression and Risk Factors as Obesity and Type 2 Diabetes Mellitus
Eldernawi, A. M., Herzalla, M. R., Zaghlol, A., Hadhoud, K. M., & Fouad, A. A. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.199599
“This close relationship also led to the connotation ‘diabesity’, highlighting the fact that the majority of individuals with diabetes are overweight or obese (5) .”
BackgroundWang, O., Han, L., Lin, H., Tian, M., Zhang, S., Duan, B., Chung, S., Zhang, C., Lian, X. L., Wang, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.11.463939
“The bodyweight drops and the fasting glucose level rise after the STZ injection indicated the progression of T2DM (Figure 3A, 3D).”
BackgroundInfluentialUnequal Cut in Limb Amputations: Diabetes and Health Disparity in the United States
Nwagbara, U. (2021) · Journal of Health, Medicine and Nursing · doi:10.7176/jhmn/95-10
Does Gastrectomy Or Diet Reduce Inflammation More In The Treatment Of Obesity?
Öztürk, M., & Kargın, S. (2022) · Eastern Journal Of Medicine · doi:10.5505/ejm.2022.93823
Zhang, H., An, X., Jin, D., Tian, J., Liu, W., Zhao, S., Wang, X., Hu, Y., Lian, F., & Tong, X. (2021) · Research Square · doi:10.21203/rs.3.rs-147873/v1
“Although there is several well-established drug classes for treating T2D, it is still a considerable unmet need for a drug that reverses diseases progression base on combined treatment strategies(8).”
BackgroundFinocchietto, P. V., Perez, H., Blanco, G. A. C., Miksztowicz, V., Marotte, C., Morales, C., Peralta, J. G., Berg, G. A., Poderoso, C., Poderoso, J. J., et al. (2020) · doi:10.22541/au.159586069.98939770
George, G., Auti, P. S., Sengupta, P., & Paul, A. T. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220314094820
Valizadeh, R., Yarigholi, F., & Gholizadeh, H. (2022) · Annals of Bariatric Surgery · doi:10.32598/abs.10.2.7
The work-health balance questionnaire: cultural adaptation and validation in Spanish
Novelo-Ramírez, H. R., Méndez-Magaña, A. C., Herrera-Godina, M. G., González-Estévez, G., Martínez-Melendres, B., Huerta-Pérez, A., & Gragnano, A. (2022) · Anales de Psicología · doi:10.6018/analesps.442221 · Cited by 1
(2021) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2021.189507
Bensaad, M. S., Dassamiour, S., Hambaba, L., Mela, M. A., Sami, R., Al-Mush, A. A. M., Benajiba, N., & Masoudi, L. M. A. (2022) · International Journal of Pharmacology · doi:10.3923/ijp.2022.1296.1308
Dalal, N., Patel, D., Chaturvedi, A., & Shah, A. V. (2022) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20222375
Chetty, L. (2022) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/4515 · Cited by 4
Aliyev, S., Mamedova, S. Y., & Aliyev, E. (2022) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202301181
Li, Y. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.16.002257
Análisis del concepto “Diabesidad”
De-la-Vega, D., Nava, J. M., Pérez, O. I., & Ramírez-Girón, N. (2022) · Index de Enfermería · doi:10.58807/indexenferm20225176 · Cited by 1
Goel, K., Singh, R., Saini, V., & Bansal, S. (2023) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2023.14.1s02.300
New Technologies to Treat Obesity and Related Comorbidities
Brunaldi, V., & Neto, M. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-21044-0_39
Endoscopic Liners (Duodenojejunal Bypass Liner, Gastroduodenojejunal Bypass Sleeve)
Gersin, K. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-21044-0_37
Commentary on "The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus"
Cho, W. K. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2322046edi06 · Cited by 1
The Attitude of type 2 Diabetic Patients Toward Intensive Weight Management and Bariatric Surgery
Alotaibi, K. F., Altokhais, M. A., Alburayk, A. K., Almutairi, F. E., Alotaibi, H. F., & Kofi, M. A. (2023) · Acta Scientifci Nutritional Health · doi:10.31080/asnh.2023.07.1234
Waqar, A., Chaudhry, B., Haq, I. U., & Nawaz, A. (2023) · Proceedings of the Pakistan Academy of Sciences B Life and Environmental Sciences · doi:10.53560/ppasb(60-2)871
Time to revisit the true role of metformin in type 2 diabetes mellitus
López‐Candales, A., Monte, S. V., Sawalha, K., & Norgard, N. B. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2224036
“Notwithstanding, hyperglycemia has also become more common given its robust association with obesity [18,19].”
BackgroundPrevalencia de sobrepeso y obesidad en adultos con diabetes tipo 2 de Sinaloa, México
Miranda-Félix, P. E., Sombra, F. G. B., & Ortiz-Félix, R. E. (2023) · SANUS · doi:10.36789/revsanus.vi1.333 · Cited by 2
Nyongesa, M. G., Barasa, R. D., Kiptoo, A., & Martin, D. R. (2023) · Pan Africa Science Journal · doi:10.47787/pasj.v3i02.24
Hakeem, R., Rashid, T., & Sheikh, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22106-4.00004-8
Association of adiponectin with thyroid dysfunction in diabetes mellitus type II
Abd-Alhussain, S. Q., & Sallman, O. S. (2024) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2024.26.2.0066
O impacto da cirurgia bariátrica na remissão e nas complicações do Diabetes Mellitus do tipo 2
da Silva, L. O., Souza, G. H. S., Heinzemann, G. L., Claudino, G. D. C., de Silveira, B. L. L., de Pinho, L. C. S., Cornacchia, C., Barbosa, P. D. S., de Moura, J. P. L. H., & Souza, B. P. C. (2024) · Research Society and Development · doi:10.33448/rsd-v13i3.45197 · Cited by 1
Review of Efficacy and Safety of Semaglutide in the Management of Obesity
Han, S., & Park, T. E. (2024) · Korean Journal of Clinical Pharmacy · doi:10.24304/kjcp.2024.34.1.1
Wu, J., Wang, M., Han, L., Zhang, H., Lei, S., Zhang, Y., & Mo, X. (2022) · Figshare · doi:10.6084/m9.figshare.20374594
Managing Obesity and Type 2 Diabetes through Lifestyle Modification: A Case Report
Dutta, P. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23814200311
“[2] Type 2 diabetes encompasses individuals who have blood sugar levels that are higher than normal, which may lead to increased insulin resistance and insulin deficiency.”
BackgroundKostadinov, N. (2024) · MEDIS – International Journal of Medical Sciences and Research · doi:10.35120/medisij030231k
Babel Health Directorate, M. O. H. A. E., Hamza, N., Kasim, A. A., & Hameed, W. E. (2024) · The Ukrainian Biochemical Journal · doi:10.15407/ubj96.03.039
Nugroho, H., Mughni, A., Putranto, I. K. A., Prasetya, A. T., & Novitasari, V. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i3.3047 · Cited by 3
Predictors of the Attempt and Failure to Lose Weight among the South African Population
Manafe, M. (2024) · Obesities · doi:10.3390/obesities4030018
“Given that the majority of people with type 2 diabetes are obese, weight reduction plays an essential role in the prevention and treatment of type 2 diabetes mellitus [10].”
BackgroundInfluentialGüven, A. T., Özdede, M., Kayaoğlu, B., Şerifli, N., Özçiçek, A., & Geleri, T. I. (2024) · Sakarya Medical Journal · doi:10.31832/smj.1458087 · Cited by 1
Cinnamon and Glucose Management
Volpe, S. L. (2024) · ACSMʼs Health & Fitness Journal · doi:10.1249/fit.0000000000000989
Content is Life: The Power of Social Media to Improve Health among Latinos
́ález-Arias, M. G. ́. (2024) · Journal of the National Hispanic Medical Association · doi:10.59867/nhma0402
Spinal cord injury-specific prognostic risk assessment tool for development of type 2 diabetes
Arnow, K. D., Harris, A. H. S., Logan, D. S., Davis‐Lopez, K. M., LaVela, S. L., Frayne, S. M., Wu, J. C., & Eisenberg, D. (2025) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2024.2434310
“This growth has mirrored the ongoing obesity epidemic, such that the significant majority of individuals with type 2 diabetes also suffer from over-weight or obesity (2).”
Research Advancements in the Treatment of Obesity with Chinese Medicine
Li, Y., & Wang, D. (2025) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2025.07(01).31
“Regarding oral medications, drugs such as Sibutramine, Orlistat, and Metformin have significant toxic side effects [24].”
The Relation between Body Mass Index and Abdominal Obesity with the Risk of Type 2 Diabetes Mellitus
Sofy, S. H. (2025) · Mağallaẗ al-tarbiyaẗ wa-al-ʻilm · doi:10.33899/edusj.2024.150751.1467
Dysglycemia-Based Chronic Disease
Via, M. A., & Mechanick, J. I. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_3
Herencia, J. A. C., Rueda, M. S., Ródenas, L. M. A., Divisón, J. A., Escribano, F. M., García, I. P., Bru, A. P., Moreno, P. T., Bernardo, D. C., López, R. M., et al. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500768 · Cited by 2
Wang, J., Cai, L., Liu, J., Zhang, F., Zhang, G., Kang, H., Ren, G., Yan, L., Zhang, Y., Pan, Z., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.026 · Cited by 3
“These diseases include type 2 diabetes mellitus, cardiovascular disorders, and different forms of cancer [3,4].”
Metabolic Disorders and Succinate Dehydrogenase
Mandlik, D. S., & Mandlik, S. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_11
Alenazi, M. A., Sabico, S., Alnaami, A. M., Wani, K., Hussain, S. D., & Al‐Daghri, N. M. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05833-z
Aladejana, A. E., Sandasi, M., & Viljoen, A. M. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.06.038
Tai, C. W. (2025) · Malaysian Family Physician · doi:10.51866/oa.767 · Cited by 1
“35 Despite the significant improvements observed in the HbA1c level, and lipid profile, the inherent limitations of this study were acknowledged, particularly concerning potential confounding factors.”
da Silva, A. A. C., Soares, L. D. L., da Silva, L. C., Clemente, A. P. G., Silva‐Neto, L. G. R., Longo‐Silva, G., Bádue, G. S., da Silveira, J. A. C., Barros-Neto, J. A., & de Menezes, R. C. E. (2025) · Revista Contemporânea · doi:10.56083/rcv5n9-068
Feliz‐Mosquea, Y. R., Wilson, A. S., Cruz‐Diaz, N., Payne, V. S., Cook, K. L., & Soto‐Pantoja, D. R. (2025) · Physiological Reports · doi:10.14814/phy2.70400
“Cardiovascular disease (CVD) is the leading cause of death worldwide; obesity and poor diet are a significant risk factors for CVD (Barnes, 2011; Leitner et al., 2017).”
Sau, A., Nanda, N., Sahoo, J., & Velkumary, S. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1084_24
“[9] Moreover, the adipose tissue quality and functionality is considered more relevant in terms of risk of CVD while compared to total adiposity, [10] which may be difficult to infer from body composition alone.”
Nguyen, T. H. T., Jeon, S., Yoon, J., & Park, B. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf287
Metadata
- Authors
- Leitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H.
- Affiliations
- University of Graz (AT)
- Instituto de Salud Carlos III (ES)
- Istanbul University-Cerrahpaşa (TR)
- Medical University of Vienna (AT)
- European Association for the Study of Obesity (GB)
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 10
- Issue
- 5
- Pages
- 483-492
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC5741209
- OpenAlex
- W2762120405
- Cited by
- 431
- References
- 76
- Citations by year
- 2026: 16 · 2025: 51 · 2024: 67 · 2023: 80 · 2022: 76 · 2021: 68 · 2020: 51 · 2019: 14 · 2018: 8
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, type 2 diabetes, diabesity, body composition, weight loss, lifestyle intervention, pharmacotherapy, bariatric surgery, glycemic control
- MeSH terms
- Adult, Child, Combined Modality Therapy, Diabetes Mellitus, Type 2, Diet, Health Services Needs and Demand, Humans, Life Style, Obesity, Exercise, Comorbidity, Anti-Obesity Agents, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.